Helios and Matheson Analytics Inc HMNY is becoming one of Wall Street's most talked about stocks after increasing in value ten-fold. The company that offers predictive analytics recently acquired a stake in the online ticketing service MoviePass for $27 million.
Reuters reported MoviePass' subscriber numbers soared from less than 20,000 to over 400,000 after the stake was announced on Aug. 15.
Wall Street took notice as Maxim Group's Brian Kinstlinger suggested his prior estimate of MoviePass boasting 2.5 million subscribers is a "conservative" figure, Reuters quoted the analyst as saying in a research report on Oct. 2.
Meanwhile, MoviePass is prepping for an initial public offering before the end of March 2018.
Not All Are Bullish
But not all across Wall Street are uber-bullish. On the contrary, notable short seller Citron Research Tweeted that Helios' stock deserves to trade lower to the $20 level as opposed to the mid-to-high $30s it was trading at on Wednesday.
Meanwhile, CNBC's Jim Cramer jumped into the debate and Tweeted at Citron: "a squeeze is a squeeze by any name." Cramer likely referenced the stock's heavily short profile in which 62 percent of the company's float is shorted, Reuters added. In other words, many investors who are short the stock are being forced to buy shares, which exasperates the move to the upside.
Helis And Matheson's stock is up more than 1,000 percent since Aug. 15.
Helios And Matheson: Even Citron's Andrew Left Can't Derail This Rally
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.